Onderneming Cellectar Biosciences Inc Nasdaq
Aandelen
US15117F3029
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Caruso
CEO | Chief Executive Officer | 65 | 15-06-15 |
Chad Kolean
DFI | Director of Finance/CFO | 59 | 28-05-14 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-23 |
Jarrod Longcor
COO | Chief Operating Officer | 51 | 15-07-16 |
Shane Lea
PRN | Corporate Officer/Principal | - | 21-11-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 07-04-17 |
Douglas Swirsky
CHM | Chairman | 54 | 07-04-17 |
John Neis
BRD | Director/Board Member | 68 | 01-02-08 |
James Caruso
CEO | Chief Executive Officer | 65 | 15-06-15 |
Stefan Loren
BRD | Director/Board Member | 60 | 15-06-15 |
Director/Board Member | 55 | 24-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 238 | 0 | 0 | 90,91 % |
Aandeel B | 0 | 111 | 0 | 0 | |
Aandeel C | 1 | 35 848 924 | 32 591 316 ( 90,91 %) | 0 |
Bedrijfsgegevens
![Adres Cellectar Biosciences Inc](https://cdn.zonebourse.com/static/address/27113358.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+62,48% | 856 mld. | |
+38,95% | 631 mld. | |
-4,04% | 359 mld. | |
+15,72% | 325 mld. | |
+8,66% | 297 mld. | |
+5,89% | 234 mld. | |
+16,53% | 226 mld. | |
+15,59% | 177 mld. | |
+1,96% | 165 mld. |